These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32832713)

  • 1. Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability.
    Negreva MN; Prodanova K; Vitlianova K; Madjova C
    Arch Med Sci Atheroscler Dis; 2020; 5():e140-e147. PubMed ID: 32832713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions.
    Negreva M; Prodanova K; Zarkova A
    J Atr Fibrillation; 2020 Aug; 13(2):2297. PubMed ID: 34950291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal atrial fibrillation is associated with early coagulation activity regardless of risk factors for embolism.
    Negreva MN; Prodanova KS; Vitlianova KD
    Minerva Cardiol Angiol; 2021 Jun; 69(3):269-276. PubMed ID: 32657551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxysmal Atrial Fibrillation: Insight Into the Intimate Mechanisms of Coagulation.
    Negreva M; Zarkova A; Prodanova K; Petrov P
    Cardiol Res; 2020 Feb; 11(1):22-32. PubMed ID: 32095193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.
    Negreva M; Georgiev S; Prodanova K; Nikolova J
    Cardiol Res; 2016 Jun; 7(3):89-94. PubMed ID: 28197274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
    Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
    Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
    Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Activity of the Protein C Anticoagulant Pathway in the Early Hours of Paroxysmal Atrial Fibrillation.
    Negreva M; Georgiev S; Vitlianova K
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):793-799. PubMed ID: 27313201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationships between Atrial Electromechanical Delay and CHA2DS2-VASc Score in Patients Diagnosed with Paroxysmal AF.
    Nar G; İnci S; Aksan G; Soylu K; Demirelli S; Nar R
    Echocardiography; 2015 Sep; 32(9):1359-66. PubMed ID: 25470534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of the serum endocan level with the CHA
    Ceyhun G
    Egypt Heart J; 2021 Jan; 73(1):9. PubMed ID: 33443627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
    Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
    Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA
    Głowicki B; Matusik PT; Plens K; Undas A
    Can J Cardiol; 2019 May; 35(5):634-643. PubMed ID: 30955928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
    Jia XQ; Dong CM; Qin J; Zhang L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis.
    Negreva M; Georgiev S; Vitlianova K
    Medicine (Baltimore); 2016 Nov; 95(45):e5184. PubMed ID: 27828845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
    Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
    J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.